MoonLake Immunotherapeutics (MLTX) Stock Research

MoonLake Immunotherapeutics

· MLTX

Dashboard

Financials

Ratios

Valuation

Statistics

974.472 M

+2.18%

Over a week ago

Wedbush biotech analyst holds an analyst/industry conference call

Sep 21, 9:53 AM

MoonLake price target raised to $50 from $45 at H.C. Wainwright

MLTX

Aug 13, 6:14 AM

MoonLake shares drop 11% pre-market after Q2 earnings, Phase 3 trial results

MLTX

Aug 10, 7:45 AM

MoonLake Immunotherapeutics reports Q2 EPS (84c), consensus (90c)

MLTX

Aug 10, 7:40 AM

MoonLake says Phase 3 IZAR-1 trial met all clinical endpoints at Week 16

MLTX

Aug 10, 7:39 AM

MoonLake Immunotherapeutics 9M share Secondary priced at $20.00

MLTX

Jun 24, 6:20 AM

Closing Bell Movers: Avis Budget jumps over 6% on Pentwater settlement

Jun 22, 7:40 PM

What You Missed On Wall Street On Monday

+33

Jun 22, 4:11 PM

MoonLake Immunotherapeutics announces $150M offering of Class A ordinary shares

MLTX

Jun 22, 4:07 PM

MoonLake's SLK has 'blockbuster potential,' says Clear Street

MLTX

Jun 22, 1:41 PM

Midday Fly By: Chevron signs power deal with Microsoft, CRH to acquire Arcosa

+33

Jun 22, 12:01 PM

MoonLake announces Week 52 results of Phase 3 VELA-1, VELA-2 trials

MLTX

Jun 21, 9:18 PM

MoonLake price target raised to $45 from $40 at H.C. Wainwright

MLTX

May 11, 5:59 AM

MoonLake FDA meeting yields 'best-in-class' label, says Clear Street

MLTX

May 10, 3:08 PM

MoonLake Immunotherapeutics reports Q1 EPS -98c vs. -91c last year

MLTX

May 10, 2:49 PM

MoonLake says aligned with FDA on submission plans for sonelokimab

MLTX

May 10, 2:48 PM

MoonLake Immunotherapeutics announces results from Phase 3 VELA-1, VELA-2 trial

MLTX

Mar 29, 10:34 AM

MoonLake Immunotherapeutics management to meet with BTIG

MLTX

Mar 26, 1:24 PM

MoonLake upgraded to Outperform from Underperform at Wolfe Research

MLTX

Mar 23, 5:43 AM

Micron downgraded, Five Below upgraded: Wall Street's top analyst calls

+12

Mar 19, 9:39 AM

MoonLake upgraded to Buy from Neutral at Rothschild & Co Redburn

MLTX

Mar 19, 4:47 AM

MoonLake price target raised to $70 from $45 at Clear Street

MLTX

Mar 11, 6:31 AM

MoonLake Immunotherapeutics price target raised by $8 at H.C. Wainwright, here's why

MLTX

Mar 2, 6:11 AM

MoonLake Immunotherapeutics price target raised by $1 at Goldman Sachs, here's why

MLTX

Feb 26, 7:30 AM

Charts